10-Aug-2026
Privia Health Group (PRVA) Gets a Buy from Citi
TipRanks (Mon, 10-Aug 4:35 PM ET)
TipRanks (Mon, 10-Aug 5:35 AM ET)
Analysts Are Bullish on Top Healthcare Stocks: Janux Therapeutics Inc (JANX), Cytokinetics (CYTK)
TipRanks (Fri, 7-Aug 11:40 AM ET)
Piper Sandler Remains a Buy on Privia Health Group (PRVA)
TipRanks (Fri, 7-Aug 8:10 AM ET)
RBC Capital Sticks to Its Buy Rating for Privia Health Group (PRVA)
TipRanks (Fri, 7-Aug 7:09 AM ET)
Privia Health earnings call highlights growth and margins
TipRanks (Thu, 6-Aug 8:14 PM ET)
TipRanks (Thu, 6-Aug 1:50 PM ET)
Evercore ISI Remains a Buy on Privia Health Group (PRVA)
TipRanks (Thu, 6-Aug 11:06 AM ET)
Privia Health Group Non-GAAP EPS of $0.19 misses by $0.05, revenue of $632.6M beats by $31.84M
Seeking Alpha News (Thu, 6-Aug 6:12 AM ET)
Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results
Globe Newswire (Thu, 6-Aug 6:00 AM ET)
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
Privia Health Group trades on the NASDAQ stock market under the symbol PRVA.
As of August 10, 2026, PRVA stock price declined to $22.37 with 1,155,703 million shares trading.
PRVA has a beta of 0.45, meaning it tends to be less sensitive to market movements. PRVA has a correlation of 0.03 to the broad based SPY ETF.
PRVA has a market cap of $2.86 billion. This is considered a Mid Cap stock.
Last quarter Privia Health Group reported $633 million in Revenue and $.19 earnings per share. This beat revenue expectation by $36 million and missed earnings estimates by -$.02.
In the last 3 years, PRVA traded as high as $28.82 and as low as $15.92.
The top ETF exchange traded funds that PRVA belongs to (by Net Assets): IJR, VTI, IWM, VB, VBK.
PRVA has underperformed the market in the last year with a price return of +14.7% while the SPY ETF gained +23.5%. PRVA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -6.8% and -12.3%, respectively, while the SPY returned +5.9% and +4.6%, respectively.
PRVA support price is $21.88 and resistance is $23.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRVA shares will trade within this expected range on the day.